NEVVI Medicare utilization intelligence
or

← back

Provider profile

PHULL, POOJA MD

Hematology-Oncology · NPI 1104245315 · HACKENSACK, NJ

1
Groups
15
Codes · 2024
3,876
Disclosed services

PHULL, POOJA is a Hematology-Oncology in HACKENSACK, NJ, a member of 1 medical group, who billed 15 distinct codes to Medicare Part B in 2024.

Groups: REGIONAL CANCER CARE ASSOCIATES LLC (HACKENSACK, NJ)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒

Provider overview · all codes · CY2024

3,876
disclosed services
15
codes billed to Medicare Part B
Prior year · CY2023 5,023 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
96372 Injection of drug or substance under skin or into muscle
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
85097 Bone marrow, smear interpretation
99238 Hospital discharge day management, 30 minutes or less
38220 Aspiration of bone marrow sample for diagnosis
38221 Biopsy of bone marrow
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.